News & events

3 December 2022. Engaging in Advocacy
NEWS

“The ‘P’ Word: the challenge of urinary problems in people living with prostate and bladder cancer”

Join us for a policy discussion on December 7, 2022, at the European Parliament in Brussels, Belgium.

Learn more
29 November 2022. Building Community
NEWS

Blåscancerförbundet joins WBCPC community

WBCPC welcomes to the coalition the Swedish Bladder Cancer Society which supports people affected by bladder cancer

Learn more
25 November 2022. Building Community
EVENTS

WBCPC team at the SIU42 Annual Congress in Montreal, Canada

Our team travelled to Montreal, Canada, for the Annual Congress organised by Société Internationale d’Urologie, to meet with urologists from across the globe.

Learn more
23 November 2022. Raising Awareness
EVENTS

Speaker reflections from the #BladderCancerForum22

Sarah Collen, EU Policy Manager at the European Association of Urology, discussed the importance of building partnerships at European and International levels at the World Bladder Cancer Patient Forum 2022.

It is important to work with other stakeholders, to build coalitions, to work in partnership with others, to work together so that the voice of bladder cancer patients can be heard at political levels, both in the EU, with WHO and Internationally
Learn more
9 November 2022. Raising Awareness

Speaker reflections from the #BladderCancerForum22

Dr Ignacio Durán discusses the fundamental role of patient advocacy groups in improving bladder cancer information and support for patients around the globe at the World Bladder Cancer Patient Forum 2022.

Patient groups have a role in the whole structure of treatment. Healthcare professionals can do so much but cannot cover everything.
Learn more
8 November 2022. Engaging in Advocacy
EVENTS

Increasing speed, accessibility and effectiveness of screening – 8th World Cancer Series

WBCPC Executive Director, Alex Filicevas, discusses the importance of increasing the speed, accessibility and effectiveness of screening in cancer at the Economist’s World Cancer Series: Europe 2022

Extending the screening programmes to more cancer types, including bladder cancer, is crucial – collaboration to advance research is how we can make that happen. We also need to measure, evaluate and continuously learn about efficiency of existing programmes and adapt in line with advancement in technology and research.
Learn more

You may be interested in